A global comparison of the cost of patented cancer drugs in relation to global differences in wealth

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population2015 · 141 citations
2. 2"We all have AIDS": case for reducing the cost of HIV drugs to zero Commentary: The reality of treating HIV and AIDS in poor countries Commentary: Most South Africans cannot afford anti-HIV drugs2002 · 29 citations
3. 3Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis2013 · 698 citations
4. 4Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis2016 · 250 citations
5. 5Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer2015 · 118 citations